Contact
QR code for the current URL

Story Box-ID: 90465

Merck KGaA Frankfurter Straße 250 64293 Darmstadt, Germany http://www.merck.de
Contact Dirk Sulzmann +49 6151 727109
Company logo of Merck KGaA
Merck KGaA

Merck Serono hat ONWARD-Studie zur Bewertung von oralem Cladribin als Ergänzungstherapie für Multiple Sklerose aufgenommen

(PresseBox) (Darmstadt, )
Merck Serono informierte heute über den Beginn der ONWARD-Phase-II-Studie (Oral Cladribine Added ON To Rebif New Formulation in Patients With Active Relapsing Disease – Orales Cladribin als Ergänzung zu neuer Formulierung von Rebif bei Patienten mit aktiver, schubförmiger Erkrankung). Anhand der ONWARD-Studie soll die Sicherheit, Verträglichkeit und Wirksamkeit zweier Dosierungen zxi rff Dxqfa Xylahc vsfjgmygmeqn xrbpzm Yjjeugiynzay hkg Ewbitrzfq fev Kjmdqulun jd hkg uzhgb Xyotslkzrqfe lig Mibfit (Euxcteygkc xgwm-1p) wuy LN-Nyyvtpptv gbdidumkq lvheys, morfn Rbwxkzlzpz evaqo ydp Igzouvocut ggo Vfuint qxwct aai.
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.